9th Annual Biomarkers Congress

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2012 Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate Photochem Photobiol Sci. 2012 Jan 11. PMID:22234658
2. 2012 Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting Eur J Med Chem. 2012 Jan; 47(1):560-72. PMCID:PMC3243070
3. 2012 Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W(80)5EC combined with approved seasonal influenza antigens Vaccine, 2012 Jan 5;30(2):307-16. PMID:22079079
4. 2012 Biophysical characterization of a riboflavin-conjuated dendrimer platform for targeted drug delivery Biomacromolecules, 2012 Jan 18. PMID:22191828
5. 2012 Induction of immune tolerance in mice with a novel mucosal nanoemulsion adjuvant and self-antigen Nanomedicine, 2012. In Press.
6. 2011 The need to pursue and publish clinical trials in nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 3(4), 341-2, 2011.
7. 2011 Novel poly (EthyleneAmidoAmine)(PETAA) dendrimers produced through a unique and highly efficient synthesis. Polymer 52 (2011) 5975-5984.
8. 2011 Optical fiber-based in vivo quantification of growth factor receptors Cancer 2011. NIHMS#312755
9. 2011 In vitro antibacterial activity of NB-003 against propionibacterium acnes Antimicrob Agents Chemother 55(9), 4211-7, 2011.
10. 2011 Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum 63(9), 2671-80, 2011. PMCID: PMC3168725
11. 2011 Targeted dendrimer chemotherapy in an animal model for head and neck squamous cell carcinoma J Oral Maxillofac Surg 69(9), 2452-9, 2011. PMCID: PMC3162993
12. 2011 Specificity and negative cooperativity in dendrimer-oxime drug complexation Macromolecules (Communication) 44(11), 4026-4029, 2011
13. 2011 A novel inactivated intranasal respiratory syncytial virus vaccine promotes viral clearance without Th2 associated vaccine-enhanced disease PLoS One 6(7), e21823, 2011. PMCID: PMC3137595
14. 2011 Bioanalytical screening of riboflavin antagonists for targeted drug deliver – a thermodynamic and kinetic study ACS Med Chem Lett 2(5), 363-67, 2011. PMCID: PMC3114641
15. 2011 Acetonitrile shortage: use of isopropanol as an alternative elution system for ultra/high performance liquid chromatography. Anal Methods 3(1), 56-58, 2011. PMCID: PMC3092165
16. 2011 Intranasal immunization of ferrets with commercial trivalent influenza vaccines formulated in a nanoemulsion-based adjuvant Clin Vaccine Immunol 18(7), 1167-75, 2011
17. 2011 Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer-methotrexate conjugate as a potential anticancer agent. Bioorg Med Chem 19(8), 2557-64, 2011. PMCID: PMC3130541
18. 2011 Chapter 27, Immunopathogenesis of Thyroiditis In: Immunoendocrinology: Scientific and Clinical Aspects. George S Eisenbarth (ed.), Humana Press, 1st Edition, 443-456, 2011.
19. 2011 A photochemical approach for controlled drug release in targeted drug delivery Bioorg Med Chem. 2011 Dec 20. NIHMS#346027
20. 2011 Design, synthesis, and biological functionality of a dendrimer-based modular drug delivery platform Bioconjug Chem 22(4), 679-89, 2011. PMCID: PMC3089944
21. 2011 Copper-free click conjugation of methotrexate to a PAMAM dendrimer platform Tetrahedron Lett, 52(13), 1411-1414, 2011. PMCID: PMC3048335
22. 2010 Light-controlled release of caged doxorubicin from folate receptor-targeting PAMAM dendrimer nanoconjugate Chem Comm 46(15), 2632-34, 2010. PMCID: PMC2901837
23. 2010 Real-time small molecule binding detection using a label-free photonic crystal biosensor Proc of SPIE, 7553, 755303, 2010, DOI: 10.1117/12.846011.
24. 2010 Topical nanoemulsion therapy reduces bacterial wound infection and inflammation after burn injury Surgery 148(3), 499-509, 2010. PMCID: PMC2891388
25. 2010 Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant Crit Rev Immunol 30(2), 189-199, 2010. PMCID: PMC2860868
26. 2010 Understanding specific and nonspecific toxicities; a requirement for the development of dendrimer-based pharmaceuticals Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(3), 249-59, 2010. PMCID: PMC2905802
27. 2010 Efficacy, immunogenicity and stability of a novel intranasal nanoemulsion-adjuvanted influenza vaccine in a murine model Hum Vaccin 6(7), 585-594, 2010
28. 2010 Real-time biomolecular binding detection using a sensitive photonic crystal biosensor Anal. Chem. 82(12), 5211-5218, 2010. PMCID: PMC2917384
29. 2010 Novel follicular-targeted nanoemulsion for acne J Amer Acadamy Derm 62(3), AB24-AB24 Suppl S, 2010.
30. 2010 Induction of immune response to the 17 kDa OMPA Burkholderia cenocepacia polypeptide and protection against pulmonary infection in mice after nasal vaccination with an OMP nanoemulsion-based vaccine Med Microbiol Immunol 199(2), 81-92, 2010
31. 2010 The influence of dendrimer surface charge on the bioactivity of 2-methoxyestradiol complexed with dendrimers. Soft Matter 6(11), 2539-2545, 2010. PMCID: PMC1278791
32. 2010 Fiber-optic multiphoton flow cytometry in whole blood and in vivo. J Biomed Optics 15(4), 1 (July/Aug), 047004, 2010. PMCID: PMC2924903
33. 2010 Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted delivery Bioorg Med Chem Lett 20(17), 5191-4, 2010. PMCID: PMC2922453
34. 2010 Effect of mass transport in the synthesis of partially acetylated dendrimer: Implications for functional ligand-nanoparticle distributions Macromolecules 43(16), 6577-87, 2010. PMCID: PMC3056448
35. 2010 Isolation and characterization of dendrimer with precise numbers of functional groups Chemistry 16(35), 10675-8, 2010. PMCID: PMC2942990
36. 2010 Plasma-mediated release of morphine from synthesized prodrugs Bioorg Med Chem Lett 20(21), 6250-3, 2010
37. 2010 Differentiating dental pulp cells via RGD-dendrimer conjugates J Dent Res 89(12), 1433-8, 2010.
38. 2010 Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines. J Aerosol Med & Pulmonary Drug Delivery 23(2), 77-89, 2010
39. 2010 Progress in Cancer Nanotechnology In: Progress in Molecular Biology and Translational Science, Vol 95, Molecular Biology of Cancer: Translation to the Clinic. Ruddon RW (ed.), Academic Press, pg 193-236, 2010
40. 2010 Quantitation differentiation of dyes with overlapping one-photon spectra by femtosecond pulse-shaping J Luminescence 130(1), 29-34, 2010. PMCID: PMC2772214
41. 2010 Targeted dendrimeric anticancer prodrug: A methotrexate-folic acid poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach. Bioconjugate Chem 21(3), 489-495, 2010. PMCID: PMC2892195
42. 2010 Progress in cancer nanotechnology. Prog Mol Biol Transl Sci 95, 193-236, 2010.
43. 2010 A quantitative assessment of nanoparticle-ligand distributions: Implications for targeted drug and imaging delivery in dendrimer conjugates   ACS Nano 4(2), 657-70, 2010. PMCID: PMC2836386
44. 2010 The Synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release Organic Letters 12(7), 1384-7, 2010. PMCID: PMC2851157
45. 2010 Dendrimer-based tumor cell tarteting of fibroblast growth factor-1. Bioorg Med Chem Lett 20(2), 700-3, 2010. PMCID: PMC2818523
46. 2010 The mechanism of polyplexes internationalization into cells: testing the GM1/caveolin-1-mediated lipid raft mediated endocytosis pathway Mol Pharm 7(1), 267-79, 2010. PMCID: PMC2826151
47. 2010 Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo Anticancer Drugs 21(2), 186-92, 2010. PMCID: PMC2818998
48. 2009 Polymer nanoparticles induce nanoscale disruption in living cell plasma membranes J Phys Chem B 113(32), 11179-11185, 2009. PMCID: PMC2753177
49. 2009 RGD dendron bodies; synthetic avidity agents with defined and potentially interchangeable effector sites that can substitute for antibodies Bioconj Chem 20(10), 1853-59, 2009. PMCID: PMC2920625
50. 2009 Dendrimer-based nanoparticles for cancer therapy Hematology Am Soc Hematol Educ Program 2009:708-19.
51. 2009 Methotrexate delivery via folate targeted dendrimer-based nanotherapeutic platform. Wiley Interdiscip Rev Nanomed Naobiotechnol 1(5), 502-10, 2009. PMCID: PMC2944777
52. 2009 Spontaneous formation of functionalized dendrimer-stabilized gold nanoparticles. J Phys Chem C 112, 8251-8258, 2009. PMCID: PMC2736051
53. 2009 Nanotechnology in Clinical and Translational Research In: Clinical and Translational Science. Principles of Human Research. Robertson D, Williams GH (eds.), Academic Press, 1st edition, pg 123-136, 2009
54. 2009 Chapter 8: Dendrimer Synthesis and Functionalization by Click Chemistry for Biomedical Applications. In: Click Chemistry for Biotechnology and Material Science, J Lahann (Ed.), Wiley Publishers, 177-193, 2009
55. 2009 In vitro activities of a novel nanoemulsion against Burkholderia and other multi-drug resistant cystic fibrosis-associated bacterial species. Antimicrob Agents Chemother 53(1), 249-55, 2009. PMCID: PMC2612147
56. 2009 Two-photon in vivo flow cytometry using a fiber probe Proc. of SPIE 7173, 717301, 2009.
57. 2009 Interactive design strategy for a multi-functional PAMAM dendrimer-based nano-therapeutic using computational models and experimental analysis. J Computational and Theoretical Nanoscience 6, 54-60, 2009. PMCID: PMC2917823
58. 2009 Development of a remanence measurement-based SQUID system with in-depth resolution for nanoparticle imaging Phys Med Biol 54(10), N177-N188, 2009. PMCID: PMC2726008
59. 2009 Therapeutic efficacy of 2-methoxyestradiol microcrystals encapsulated within polyelectrolyte multilayers Macromol Biosci 9(5), 429-436, 2009. PMCID: PMC2901834
60. 2009 Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology 150(4), 2000-07, 2009. PMCID: PMC2659286
61. 2009 Control of two-photon fluorescence of common dyes and conjugated dyes J Fluorescence 19(3), 517-32, 2009.
62. 2009 Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles. Analyst 134(7), 1379-9, 2009. PMCID: PMC2917224
63. 2009 Multifunctional dendrimer-modified multi-walled carbon nanotubes: synthesis, characterization, and in vitor cancer cell targeting and imaging Biomacromolecules 10(7), 1744-1750, 2009.
64. 2009 A facile hydrothermal synthesis of iron oxide nanoparticles with tunable magnetic properties J Phys Chem C 113(31), 13593-13599, 2009. PMCID: PMC2823489
65. 2009 Stoichiometry and structure of poly(amindoamine) dendrimer-lipid complexes. ACS Nano 3(7), 1886-1896, 2009. PMCID: PMC2888816
66. 2009 Label-free biosensing using a photonic crystal structure in a total-internal-reflection geometry. Proc of SPIE 7188, 71880B, 2009. PMCID: PMC2917834
67. 2009 Polyethyleneimine-mediated functionalization of multi-walled carbon nanotubes: synthesis, characterization and in vitro toxicity assay J Phys Chem C 113(8), 3150-3156, 2009.
68. 2009 The role of ganglioside GM(1) in cellular internalization mechanisms of poly(amidoamine) dendrimers Bioconjug Chem 20(8), 1503-1513, 2009. PMCID: PMC2826151
69. 2009 Human plasma-mediated hypoxic activation of indolequinone-based naloxone pro-drugs Bioorg Med Chem Lett 19(17), 5016-5020, 2009
70. 2009 Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells. Biopolymers 91(11), 936-42, 2009. PMCID: PMC2901835
71. 2009 Cationic poly(amidoamine) dendrimer induces lysosomal apoptotic pathway at therapeutically relevant concentrations Biomacromolecules 10(12), 3207-14, 2009. PMCID: PMC2805189
72. 2009 Surface interaction and behavior of poly(amidoamine) dendrimers: deformability and lipid bilayer disruption J Computational & Theoretical Nanoscience 6(7), 1430-1436, 2009. PMCID: PMC3048352
73. 2008 Nasal immunization with a recombinant HIV gp120 and nanoemulsion adjuvant produces Th1 polarized responses and neutralizing antibodies to primary HIV type1 isolates. AIDS Res Human Retroviruses 24(2), 271-281, 2008
74. 2008 Capillary electrophoresis of poly(amidoamine) succinamic acid dendrimers using a polyvinyl alcohol (PVA)-coated capillary Electrophoresis 29, 510-515, 2008
75. 2008 Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate J Biomater Sci Polym Ed. 19(1), 131-42, 2008
76. 2008 Autoimmune thyroid diseases In: Clinical Immunology. Principles and Practice. Rich RR, Fleisher TA, Shearer WT, et al. (eds.), Mosby Elsevier, 3rd edition, pg 1023-1033, 2008.
77. 2008 Nanotechnology. In: Cancer. Principles and Practice of Oncology. DeVita VT Jr, Lawrence TS, Rosenberg SA (eds.), Lippincott Williams & Wilkins, 8th edition, Vol 2, pg 3031-3034, 2008
78. 2008 Tumor microvasculature targeting with dendrimer-entrapped gold nanoparticles. Soft Matter 4(11), 2160-2163, 2008. PMCID: PMC3171797
79. 2008 New dendrimers: synthesis and characterization of POPAM-PAMAM hybrid dendrimers. Macromolecules 41(22), 8372-7379, 2008. PMCID: PMC2736051
80. 2008 Interactions of poly(amidoamine) dendrimers with survanta lung surfactant: the importance of lipid domains Langmuir 24(19), 11003-8, 2008. PMCID: PMC2917325
81. 2008 Control of the blue fluorescent protein with advanced evolutionary pulse shaping Biochem and Biphys Res Commun 376, 733-737, 2008. PMCID: PMC2600451
82. 2008 Extended cavity laser enhanced two-photon flow cytometry J Biomed Optics 13(4), 041319, 2008.
83. 2008 Mullen DG, Desai AM, Waddell JN, Cheng XM, Kelly CV, McNerny DQ, Majoros IJ, Baker JR Jr, Sander LM, Orr BG, Banaszak Holl MM Bioconjug Chem 19(9), 1748-52, 2008. PMCID: PMC2652353
84. 2008 HER2 specific delivery of methotrexate by dendrimer conjugated anti-HER@ mAb. Nanotechnology 19, 295102, 2008; at stacks.iop.org/Nano/19/295102. PMCID: PMC2913620
85. 2008 Errata: Quantitative two-photon flow cytometry - in vitro and in vivo J Biomed Optics 13(5), 059801, 2008
86. 2008 Quantitative two-photon flow cytometry – in vitro and in vivo. J Biomed Optics 13(3), 034008, 2008. Corrected article by publisher
87. 2008 Poly(amidoamine) dendrimers on lipid bilayers I: Free energy and conformation of binding. J Phys Chem B 112(31), 9337-45, 2008. PMCID: PMC2925445
88. 2008 Two-photon fluorescence correlation spectroscopy through a dual-clad optical fiber Opt Express 16(17), 12640-9, 2008.
89. 2008 Pre-clinical evaluation of a novel nanoemulsion-based Hepatitis B mucosal vaccine PLoS ONE 3(8), e2954, 2008; doi:10.1371/journal.pone.0002954. PMCID: PMC2496893
90. 2008 Targeted gadolinium-loaded dendrimer nanoparticles for tumor-specific magnetic resonance contrast enhancement Int J Nanomedicine 3(2), 201-210, 2008. PMCID: PMC 2527674
91. 2008 Sensitive molecular binding assay using a photonic crystal structure in total internal reflection Opt Express 16(16), 11741-749, 2008. PMCID: PMC2917382
92. 2008 In vivo monitoring of multiple circulating cell populations using two-photon flow cytometry Optics Comm 281, 888-894, 2008. PMCID: PMC2352153
93. 2008 Acetylation of dendrimer-entrapped gold and silver nanoparticles. J Mater Chem 18, 586-93, 2008
94. 2008 A novel, killed-virus nasal vaccinia vaccine Clin Vac Immunol 15(2), 348-58, 2008. PMCID: PMC2238057
95. 2008 Dendrimer-functionalized shell-crosslinked iron oxide nanoparticles for in vivo magnetic resonance imaging of tumors Advanced Materials 20, 1671-78, 2008
96. 2008 Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic acid-conjugated dendrimers. ACS Nano 2(4), 773-783, 2008
97. 2008 Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers Nano Letters 8(2), 420-424, 2008
98. 2008 Investigation of tumor cell targeting of a dendrimer nanoparticle using a double-clad optical fiber probe. J Biomed Optics 13(1), 014024-1 – 014024-6, 2008
99. 2008 Dendrimer-epidermal growth factor conjugate displays super agonist activity Biomacromolecules 9, 603-609, 2008.
100. 2008 Preclinical antitumor efficacy evaluation of dendrimer-based methotrexate conjugates. Anticancer Drugs 19(2), 143-9, 2008
101. 2007 Two-photon, two-color in vivo flow cytometry to noninvasively monitor multiple circulating cell lines Multiphoton Microscopy in the Biomedical Sciences VI, Proceedings of SPIE 6631, 2007
102. 2007 Nanoparticle Interactions with Biological Membranes: Dendrimers as Experimental Exemplars and a Proposed Physical Mechanism. In: Nanotoxicology: Characterization, Dosing, and Health Effects. Tran and Monteiro-Riviere (eds.), Informa Healthcare USA, New York, 99-113, 2007
103. 2007 Poly(amidoamine) Dendrimer-Based Multifunctional Nanoparticles. In: Nanobiotechnology II. More Concepts and Applications. Mirkin CA, Niemeyer CM (eds.), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 305-319, 2007
104. 2007 Nanoparticles in Medical Diagnostics and Therapuetics In: Nanotechnology in Biology and Medicine: Methods, Devices, and Applications, Vo-Dinh, T (ed), CRC Press Taylor & Francis Group, Oxford UK, 31.1–31.22, 2007.
105. 2007 The role of apoptosis in thyroid autoimmunity Thyroid 17(10), 975-979, 2007.
106. 2007 Dendrimer-based BH3 conjugate that targets human carcinoma cells. Biomacromolecules 8(10), 2986-2989, 2007
107. 2007 Synthetic PAMAM-RGD conjugates target and bind to odontoblast-like MDPC 23 cells and the predentin in tooth organ cultures Bioconjug Chem 18(6), 1756-62, 2007
108. 2007 Microarray analysis of cytokine activation of apoptosis pathways in the thyroid Endocrinology 148(10), 4844-52, 2007
109. 2007 Dendrimer-functionalized iron oxide nanoparticles for specific targeting and imaging of cancer cells Adv Funct Mater 17, 3043-3050, 2007.
110. 2007 Multifunctional poly(amidoamine) dendrimer-taxol conjugates: synthesis, characterization and stability J Comput Theor Nanosci 4, 1179-1187, 2007.
111. 2007 Synthesis, characterization, and intracellular uptake of carboxyl-terminated poly(amidoamine) dendrimer-stabilized iron oxide nanoparticles. Phys Chem Chem Phys (PCCP) 9(42), 5712-20, 2007.
112. 2007 Whole spectrum fluorescence detection with ultrafast white light excitation Optics Express 15(16), 10439-10445, 2007
113. 2007 Dendrimer-entrapped gold nanoparticles as a platform for cancer cell targeting and imaging. Small 3(7), 1245-1252, 2007
114. 2007 Dendrimer-based nanomedicine: engineered nanodevice synthesis, characterization, and biological testing Biokémia 31:9-16, 2007
115. 2007 Improved biocompatibility of surface functionalized dendrimer-entrapped gold nanoparticles. Soft Matter 3:71-74, 2007.
116. 2007 Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against B. anthracis spore challenge Infect Immun 75(8): 4020-4029, 2007; doi: 10.1128/IAI.00070-07v1.
117. 2007 The binding of avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14(1):107-15, 2007
118. 2007 Dendrimer-based targeted delivery of an apoptotic sensor in cancer cells. Biomacromolecules 8(1):13-18, 2007
119. 2006 Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug Chem, 17(3):728-734, 2006.
120. 2006 Electrophoretic mobility and molecular distribution studies of poly(amidoamine) dendrimers of defined charges Electrophoresis 27(9):1758-1767, 2006
121. 2006 Molecular dynamics studies of the size, shape, and internal structure of 0% and 90% acetylated fifth-generation polyamidoamine dendrimers in water and methanol J Phys Chem B 110:4014-4019, 2006
122. 2006 HPLC analysis of functionalized poly(amidoamine) dendrimers and the interaction between a folate-dendrimer conjugate and folate binding protein Analyst 131(7):842-848, 2006.
123. 2006 Targeting B cells in Graves' Disease Endocrinology 147(10):4559-60, 2006.
124. 2006 HER 2 specific tumor targeting with dendrimer conjugated anti-HER2 mAb Bioconjug Chem 17(5):1109-1115, 2006.
125. 2006 Tissue distribution and real-time fluorescence measurement of a tumor-targeted nanodevice by a two photon optical fiber fluorescence probe. Proceedings of SPIE 6095:60950Q, 2006.
126. 2006 Synthesis, characterization, and manipulation of dendrimer-stabilized iron sulfide nanoparticles. Nanotechnology 17:4554-4560, 2006; web release date: DOI 10.1088/0957-4484/17/18/005
127. 2006 Increasing two-photon fluorescence signals by coherent control. Proceedings of the SPIE 6089:608910-1, 2006
128. 2006 Molecular engineering in nanotechnology: Engineered drug delivery In: Handbook of Theoretical and Computational Nanotechnology, Vols. 1-10, Rieth M, Schommers W (eds), American Scientific Publishers, Vol. 6, 673-717, 2006
129. 2006 Nantoechnology for biology and medicine In: Managing Nano-Bio-Info-Congo Innovations: Converging Technologies in Society, Bainbridge WS, Roco MC (eds), Springer, The Netherlands, 119-132, 2006.
130. 2006 Diffusion of Alexa Fluor 488-conjugated dendrimers in rat aortic tissue. Ann N Y Acad Sci 1085:294-305, 2006
131. 2006 Comprehensive characterization of surface-functionalized poly(amidoamine) dendrimers with acetamide, hydroxyl, and carboxyl groups Colloids and Surfaces A: Physiochemical Engineering Aspects 272(1-2):139-150, 2006; web release date: 8-Sept-2005, (DOI doi:10.1016/j.colsurfa.2005.07.031).
132. 2006 Encapsulation of submicrometer-sized 2-methoxyestradiol crystals into polymer multilayer capsules for biological applications. Mol Pharm 3(2):144-151, 2006; web release date: 10-Jan-2006; (DOI: 10.1021/mp050078s).
133. 2006 PAMAM dendrimer-based multifunctional conjugate for cancer therapy: synthesis, characterization, and functionality Biomacromolecules 7(2):572-579, 2006; web release date: 16-Jan-2006; (DOI: 10.1021/bm0506142)
134. 2006 Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis Analyst 131(3):374-381, 2006; web release date: 18-Jan-2006; (DOI: 10.1039/b515624f).
135. 2006 No apparent damage in the thyroid of transgenic mice expressing anti-apoptotic FLIP. Thyroid 16(1):1-8, 2006
136. 2005 Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis. Endocrinology 146(11):4721-4726, 2005; DOI: 10.1210/3n.2005-0627.
137. 2005 Apoptosis in thyroid cancer In: Thyroid Cancer: A comprehensive guide to clinical management, 2nd Edition, Vol. 6. Wartofsky (ed), Humana Press Inc. Publishers, Washington DC, 55-61, 2005
138. 2005 Targeting cancer cells with DNA-assembled dendrimers: a mix and match strategy for cancer Cell Cycle 4(5):669-671, 2005.
139. 2005 Targeting and inhibition of cell growth by an engineered dendritic nanodevice J Med Chem 48(11):3729-3735, 2005.
140. 2005 Induction and regulation of Fas-mediated apoptosis in human thyroid epithelial cells. Mol Endocrinol 19(3):804-811, 2005.
141. 2005 Lipid bilayer disruption by poly(amidoamine) dendrimers: the roles of generation and capping group Langmuir 21(23):10348-10354, 2005; (DOI: 10.1021/la050629l).
142. 2005 Generational, skeletal and substitutional diversities in generation one poly(amidoamine) dendrimers Polymer 46:3022-3034, 2005.
143. 2005 Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res 65(12):5317-5324, 2005
144. 2005 Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chem Biol 12(1):35-43, 2005
145. 2005 HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups Anal Chem 77(7):2063-2070, 2005.
146. 2005 Characterization of crystalline dendrimer-stabilized gold nanoparticles. Nanotechnology 17:1072-1078, 2006; web release date: 13-Dec-2005; (DOI 10.1088/0957-4484/17/4/038.).
147. 2005 Capillary electrophoresis of poly(amidoamine) dendrimers: from simple derivatives to complex multifunctional medical nanodevices Mol Pharm 2(4), 278-294, 2005.
148. 2005 Development of a double-clad photonic-crystal-fiber based scanning microscope. Proceedings of the SPIE 5700:23-2, 2005
149. 2005 Two-photon flow cytometry. Proceedings of SPIE Volume: 5700, Mar 2005 p. 78-89.
150. 2005 Labelling cells with silver/dendrimer nanocomposites, in Nanoscale Materials Science in Biology and Medicine, edited by Cato T Laurencin and Edward a. Botchwey (Mater. Res. Soc. Symp. Proc. 845, Warrendale PA, 2005), AA5.37., 1-6
151. 2005 Analysis of poly(amidoamine)-succinamic acid dendrimers by slab-gel electrophoresis and capillary zone electrophoresis Electrophoresis 26(15):2960-2967, 2005
152. 2005 Capillary electrophoresis of polycationic poly(amidoamine) dendrimers Electrophoresis 26(15):2949-2959, 2005.
153. 2005 Atomic force microscopy study of early morphological changes during apoptosis. Langmuir, 21(20):9280-9286, 2005; web release date: 26-Aug-2005; (DOI: 10.1021/la051837g).
154. 2005 HPLC separation of different generations of poly(amidoamine) dendrimers modified with various terminal groups Analytical Chem 77(7):2063-2070, 2005.
155. 2005 Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 5(11):2123-2130, 2005; web release date: 11-Oct-2005; (DOI: 10.1021/nl051077u).
156. 2005 HPLC analysis of PAMAM dendrimer based multifunctional devices. J Chromatogr B Analyt Technol Biomed Life Sci 822(1-2):21-26, 2005.
157. 2005 Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv Drug Deliv Rev 57(15):2203-2214, 2005; DOI: November 11, 2005.
158. 2005 Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates Chem Commun, 46:5739-5741, 2005; web release date: 10-Oct-2005; (DOI: 10.1039/b507350b).
159. 2005 Poly(amidoamine) dendrimer-based multi-functional engineered nanodevice for cancer therapy J Med Chem, 48(19):5829-5899, 2005; (DOI: 10.1021/jm0401863).
160. 2004 Mathematical description of dendrimer structure J Computational Theoret Nanosci 1:193-198, 2004
161. 2004 Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy Bioconjug Chem 15(6):1174-1181, 2004. Web Release (DOI): 10/8/04, 10.1021/bc0499127.)
162. 2004 In Vitro targeting of synthesized antibody-conjugated dendrimer nanoparticles Biomacromolecules 5(6):2269-2274, 2004.
163. 2004 Dendrimer-mediated cell transfection in vitro. Methods Mol Biol 245:67-82, 2004
164. 2004 Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers Chem Phys Lipids 132(1):3-14, 2004
165. 2004 Trapping cavitation bubbles with a self-focused laser beam Opt Lett, 29(18):2136-2138, 2004.
166. 2004 Interleukin-1b and tumor necrosis factor (TNF)-a sensitize human thyroid epithelial cells to TNF-related apoptosis-inducing ligand-induced apoptosis through increases in procaspase-7 and bid, and the down-regulation of p44/42 mitogen-activated protein kinase activity J Clin Endocrinol Metab 89(1):250-257, 2004
167. 2004 IFNγ sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by up-regulating Bak expression Oncogene 23:928-935, 2004
168. 2004 DNA-directed synthesis of generation 7 and 5 PAMAM dendrimer nanoclusters. Nano Lett 2004: 4(3), 391-397
169. 2004 Deformability of poly(amidoamine) dendrimers European Phys J E Soft Mater 14(1):7-16, 2004
170. 2004 Detection and analysis of tumor fluorescence using a two-photon optical fiber probe. Biophys J 86(6):3959-3965, 2004
171. 2004 A novel MEA/AFM platform for measurement of real-time, nanometric morphological alterations of electrically stimulated neuroblastoma cells. IEEE Trans on Nanobioscience 3(2):111-117, 2004.
172. 2004 Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and relation to transport Bioconjug Chem 15(4):774-782, 2004. (DOI: 10.1021/bc049962b.)
173. 2003 Acoustic detection of microbubble formation induced by enhanced optical breakdown of silver/dendrimer nanocomposites Appl Phys Lett 82(6):994-996, 2003
174. 2003 Acetylation of poly (amidoamine) dendrimers Macromolecules 36:5526-5529, 2003.
175. 2003 Nasal mucosal gene expression in allergic rhinitis patients with and without nasal polyps J Allergy Clin Immunol 112(6):1057-1063, 2003.
176. 2003 Development of immune response that protects mice from viral pneumonitis after a single intranasal immunization with influenza A virus and nanoemulsion. Vaccine 21(25-26):3801-3814, 2003.
177. 2003 Enhanced two-photon biosensing with double-clad photonic crystal fibers. Opt Lett 28(14):1224-1226, 2003
178. 2003 Inactivation of Ebola virus with a surfactant nanoemulsion Acta Trop 87(3):315-320, 2003.
179. 2003 Dendrimer-mediated cell transfection in vitro. In: Methods in Molecular Biology: Gene Delivery to Mammalian Cells: Nonviral Gene Transfer Techniques, Heiser WC (ed), Humana Press Inc., 67-82, 2003.
180. 2003 Nanotexturing gold surface with dendrimers for selective cell adhesion Proc IEEE EMBC 1:1232-1235, 2003
181. 2002 Endocrine diseases In: Medical Immunology, 10th Edition, Stites D, Terr A, Parslow T, Imboden J (eds), Simon & Schuster, 2002
182. 2002 Bioapplication of PAMAM dendrimers In: Dendrimers and Other Dendritic Polymers, Frechet JMJ, Tomalia DA (eds), John Wiley & Sons, Ltd., 2002
183. 2002 Dendritic polymer macromolecular carriers for drug delivery; using nanotechnology for drug development and delivery. Current Opin Chem Biol, 6(4):466-471, 2002
184. 2002 Imaging {Au0 -PAMAM} gold-dendrimer nanocomposites in cells. J Nanoparticle Res 4:395-403, 2002
185. 2002 Biosensing based on two-photon fluorescence measurements through optical fibers Optic Lett 27(16):1412-1414, 2002
186. 2002 Tapping mode atomic force microscopy investigation of poly(amidoamine) core-shell tecto(dendrimers) using carbon nanoprobes Langmuir 18:3127-3133, 2002
187. 2002 Prevention of influenza pneumonitis by sialic-acid conjugated dendritic polymers J Infect Dis 186(9):1222-1230, 2002.
188. 2002 Dendrimer nanocomposites in medicine Chimica OGG/Chemistry Today 5:85-40, 2002.
189. 2002 Aberrant apoptosis in thyroid epithelial cells from nodular goiters. J Clin Endocrinol Metab 87(9):4264-4272, 2002.
190. 2002 Lee I, Athey BD, Wetzel AW, Meixner W, Baker JR Jr Lee I, Athey BD, Wetzel AW, Meixner W, Baker JR Jr
191. 2002 Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19(9):1310-1316, 2002.
192. 2002 Bioterrorism: relevance to allergy and immunology in clinical practice. J Allergy Clin Immunol 109(2):214-228, 2002, Review.
193. 2002 A rapid staining technique for the detection of the initiation of germination of bacterial spores Lett Appl Microbiol 34(2):86-90, 2002.
194. 2002 Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells Cell Death Differ 9(3):274-286, 2002
195. 2002 A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms non-destructive to destructive thyroiditis in experimental autoimmune thyroiditis J Immunol 168:2470-2474, 2002.
196. 2002 The fungicidal activity of novel nanoemulsion (X8W60PC) against clinically important yeast and filamentous fungi Mycopathologia 155(4):195-201, 2002
197. 2001 Susceptibility of thyroid cancer cells to 7-hydroxystaurosporine-induced apoptosis correlates with Bcl-2 protein level Thyroid 11(8):725-731, 2001
198. 2001 Substituted β-cyclodextrins interact with PAMAM dendrimber-DNA complexes and modify transfection efficiency Biochem Biophys Res Commun 283:124-129, 2001.
199. 2001 Combination of electroporation and DNA/dendrimer complexes enhances gene transfer into murine cardiac transplants Am J Transplant, 1(4):334-338, 2001.
200. 2001 Studies using recombinant fragments of human TSH receptor reveal apparent diversity in the binding specificities of antibodies that block TSH binding to its receptor or stimulate thyroid hormone production J Clin Endocrinol Metab, 86(9):4254-4260, 2001
201. 2001 Endocrine diseases In: Medical Immunology, Parslow TG, Stites DP, Terr A, Imboden JB (eds), Appleton & Lange, Norwalk, Connecticut/San Mateo, California, 10th Ed, Chapter 32, 422-433, 2001
202. 2001 Autoimmune thyroid disease In: Clinical Immunology, 2nd Edition, Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Jr, Kotzin B (eds), Harcourt, 2001
203. 2001 Identification of carmine allergens among three carmine allergy patients. Allergy 56(1):73-77, 2001.
204. 2001 The nature of apoptosis in the thyroid and the role it may play in autoimmune thyroid disease Thyroid 11(3):245-247, 2001
205. 2001 A novel surfactant nanoemulsion with a unique non-irritant topical antimicrobial activity against bacteria, enveloped viruses and fungi Microbiol Res 156:1-7, 2001.
206. 2001 Tapping mode atomic force microscopy investigation of poly(amidoamine) dendrimers: Effects of Substrate and pH on Dendrimer Deformation Langmuir 17(9):2768-2773, 2001
207. 2001 The synthesis and testing of anti-cancer therapeutic nanodevices Biomed Microdevices 3(1):59-67, 2001.
208. 2000 Intravascular and endobronchial DNA delivery to murine lung tissue using a novel, nonviral vector Hum Gene Ther 11(10): 1385-1395, 2000.
209. 2000 Specificity questions concerning the clone 33 anti-Fas ligand antibody. Cell Death Differ 7(1):8-9, January 2000
210. 2000 Visualization and characterization of poly(amidoamine) dendrimers by atomic force microscopy Langmuir 16:5613-5616, 2000
211. 2000 The characterization of poly(amidoamine) dendrimer packing by atomic force microscopy Polymer Preprints 41:1446, 2000
212. 2000 The role of apoptosis in autoimmune endocrine disease. In: Harrison's Internal Medicine On Line, L. Jamison, Ed., 2000.
213. 2000 Apoptosis in autoimmune thyroid disease In: Graves' Disease: Pathogenesis and Treatment, Rapoport and McLachlan(eds), Boston: Kluwer Academic, 2000.
214. 2000 Prevention of murine influenza A virus pneumonitis by surfactant nanoemulsion. Antivir Chem Chemother 11(1):41-49, 2000
215. 2000 Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo Biomaterials 21(9):877-887, 2000.
216. 2000 DNA/Dendrimer complexes mediate gene transfer into murine cardiac transplants ex vivo Mol Ther 2(6):602-608, 2000
217. 2000 The use of PAMAM dendrimers for the efficient transfer of genetic material into cells. Pharm Sci Technol Today 3(7):232-245, 2000
218. 2000 Antimicrobial mechanism of action of surfactant lipid preparations in enteric gram-negative bacilli. J Appl Microbiol 89:397-403, 2000
219. 2000 2-Methoxyestradiol, an endogenous estrogen metabolite, induces thyroid cell apoptosis Molec Cellular Endocrin 165:163-172, 2000.
220. 1999 Inhibition of viral adhesion and infection by sialic-acid-conjugated dendritic polymers. Bioconjug Chem 10(2):271-278, 1999.
221. 1999 A novel surfactant nanoemulsion with broad-spectrum sporicidal activity against Bacillus species. J Infect Dis 180(6):1939-49, 1999
222. 1999 DNA complexing with polyamidoamine dendrimers: implications for transfection Bioconjug Chem 10(5):843-850, 1999
223. 1999 Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J Biol Chem 274(36):25433-25438, 1999
224. 1999 Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf nenonatal in vitro. Biochem Biophys Res Commun 264:253-261, 1999
225. 1999 Fas (CD95) expression is upregulated on papillary thyroid carcinoma. J Clin Endocrinol Metab 84(11):4246-4252, 1999
226. 1999 Characterization of FAP-1 expression and function in thyroid follicular cells Endocrinology 140(11):5431-5434, 1999
227. 1999 Immunogenetics, the HLA system & endocrine disease In: Principles and Practice of Endocrinology and Metabolism Becker, K (eds), Lippincott Williams & Wilkins, 1999
228. 1999 Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents J Virol Methods 77(2):165-177, 1999
229. 1999 1a,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death Endocrinology 140(4):1649-1656, 1999.
230. 1999 TRAIL death pathway expression and induction in thyroid follicular cells J Biol Chem 274(33):23627-23632, 1999.
231. 1998 The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo Gene Ther 5(10):1333-1339, 1998.
232. 1998 Technical Comment: An examination of the expression of Fas and its ligand on thyrocytes Science 279:2015-2016, 1998.
233. 1998 Therapeutic nanodevices In: Biological Molecules in Nanotechnology. The Convergence of Biotechnology, Polymer Chemistry, and Materials Science, Lee SC (ed), IBC Library Series, Southborough, MA, 1998
234. 1998 Gene transfer using Starburst dendrimers In: Self-Assembling Complexes for Gene Delivery from Laboratory to Clinical Trial, Kabanov AV, Felgner PL, Seymour LW (eds), John Wiley & Sons, New York, 241-253, 1998
235. 1998 Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers. Hum Gene Ther 9(4):553-560, 1998
236. 1997 The interaction of plasmid DNA with polyamidoamine dendrimers: mechanism of complex formation and analysis of alterations induced in nuclease sensitivity and transcriptional activity of the complexed DNA Biochim Biophys Acta 1353(2):180-190, 1997
237. 1997 Fas (AP0-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor Endocrinology 138(11):5019-5027, 1997.
238. 1997 Immunomodulators. In: Medical Immunology, DP Stites DP, Terr A, Parslow TG (eds), Appleton & Lange, Norwalk, Connecticut/San Mateo, California, 9th Ed, Chapter 59, 846-851, 1997
239. 1996 Unique autoantibody epitopes in an immunodominant region of thyroid peroxidase. J Biol Chem 271(9):4966-4973, 1996.
240. 1996 Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection Transplantation 61:722-729, 1996.
241. 1996 Allergy and immunology JAMA 275(23):1794-1795, 1996.
242. 1996 Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers Proc Natl Acad Sci USA 93(10):4897-4902, 1996.
243. 1996 Thyroiditis In: Conn's Current Therapy, Robert ER (ed), WB Saunders Company, 634-641, 1996
244. 1996 Efficient transfer of genetic material into mammalian cells using Starburst dendrimer as synthetic vectors In: Artificial Self-Assembling Systems for Gene Delivery, Felgner PL, Heller MJ, Lehn P, Behr JP, Szoka JR FC (eds), American Chemical Society, Washington, DC, 129-145, 1996
245. 1996 Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using Starburst PAMAM dendrimers. Nucleic Acids Res 24(11):2176-2182, 1996.
246. 1995 Adverse effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia J Allergy Clin Immunol 95(5/1):1053-1055, 1995
247. 1995 High efficiency prokaryotic expression and purification of a portion of the hepatitis C core protein and analysis of the immune response to recombinant protein in BALB/c mice Viral Immunol 8(2):109-119, 1995
248. 1994 Permanent reversal of diabetes in nonobese diabetic mice treated with Mycobacterium bovis BCG or bacterial superantigen Vaccine Research 3(3): 117-128, 1994
249. 1994 An analysis of the structure and antigenicity of different forms of human thyroid peroxidase Thyroid 4:173-178, 1994
250. 1993 Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease J Clin Endocrinol Metab 77(2):433-438, 1993
251. 1993 Dissecting the immune response to the thyrotropin receptor in autoimmune thyroid disease. J Clin Endocrinol Metab 77(1):16-18, 1993.
252. 1993 TSH beta subunit gene expression in human lymphocytes Am J Med Sci 305(1):1-7, 1993.
253. 1993 Superantigen-like T cell subset alterations in non-obese diabetic (NOD) mice successfully treated with bacillus calmette-guerin (BCG). J Aller Clin Immunol 91:231, Jan 1993.
254. 1993 Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis J Clin Endocrinol Metab 77(4):1098-1101, 1993.
255. 1992 Natural killer cell activity from pregnant subjects is modulated by RU 486. Am J Obstet Gynecol 166 (1/1):87-90, 1992
256. 1992 Identification of localized autoantibody epitopes in thyroid peroxidase J Clin Endocrinol Metab 75(1):121-126, 1992
257. 1992 Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease J Clin Endocrinol Metab 75 (1):295-300, 1992.
258. 1992 T-lymphocyte activation in adult-onset idiopathic hypoparathyroidism. Am J Med 92(4):352-356, 1992
259. 1992 Ex vivo gene therapy of familial hypercholesterolemia   Hum Gen Ther 3(2):179-222, 1992.
260. 1992 The immune response in chronic hepatitis B virus infection: the “core” of the problem? Hepatology 16(2):498-500, 1992
261. 1992 Ex vivo gene therapy of familial hypercholesterolemia. Hum Gene Ther 3(2):179-222, 1992.
262. 1992 Analysis of human TSH receptor gene and RNA transcripts in patients with thyroid disorders Autoimmunity 13:43-50, 1992
263. 1991 AMB A I content of Ambrosia Artemisiifolia [short ragweed (SRW)] and A. Trifida [giant ragweed (GRW)] pollens. J Aller Clin Immunol (Suppl.) 87:187, 1991
264. 1991 Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease Clin Res 39:376A, 1991.
265. 1991 Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits Science 254(5039):1802-1805, 1991
266. 1991 Thyroid stimulating and thyrotrophin binding-inhibitory immunoglobulin activity in patients with systemic lupus erythematous having thyroid function abnormalities. Thyroid 1(3):229-234, 1991.
267. 1991 Absence of retroviral sequences in Graves' disease Lancet 337(8732):17-18, 1991.
268. 1990 Hypersensitivity reactions from taxol J Clin Oncol 8:1263-1268, 1990
269. 1990 Thyrotropin gene expression in human lymphocytes Clin Res 38:296A, 1990
270. 1990 The search for retroviral DNA sequences in genomic DNA sequences isolated from patients with Graves' disease Clin Res 38:383A, 1990.
271. 1990 Hairy cell leukemia in two siblings. A human leukocyte antigen-linked disease? Cancer 65:319-321, 1990.
272. 1990 Transplantation in the military: state of the art—a progress report from the Army-Navy Transplant Program Mil Med 155(9):411-413, 1990
273. 1990 Immunogenetics, the HLA system and endocrine disease In: The Principles and Practice of Endocrinology and Metabolism, Becker KL (ed), JB Lippincott & Co, 1401-1404, 1990.
274. 1990 Endocrine diseases In: Basic and Clinical Immunology, Stites DP, Terr A (eds), Appleton & Lange, Norwalk, Connecticut/San Mateo, California, 464-475, 1990
275. 1989 Immunologic disorders of the endocrine system. J Allergy Clin Immunol 84(6/2):1088-1092, 1989.
276. 1989 Immunoglobulin composition of three commercially available intravenous immunoglobulin preparations J Allergy Clin Immunol 84(4/1):556-561, 1989
277. 1989 Binding of thyrotropin to selected Mycoplasma species: detection of serum antibodies against a specific Mycoplasma membrane antigen in patients with autoimmune thyroid disease. J Endocrinol Invest 12(2):77-86, 1989.
278. 1989 Molecular genetic detection of polyclonal immune response in autoimmune thyroiditis and inflammatory bowel disease Monatsschr Kinderheilkd 137:610-615, 1989.
279. 1989 Localization of thyroid autoantigens and disease-specific differences Endocrinol (Suppl.) T119-75A, 1989.
280. 1989 Unusual cytoplasmic nucleoproteins are autoantigens in Graves' disease (GD) Clin Res 37:934A, 1989
281. 1989 Identification of thyroid histones as auto-antigens using human monoclonal antibodies Clin Res 37:356, 1989.
282. 1989 HLA antigen contamination of commercial Western blot strips for detecting human immunodeficiency virus J Infect Dis 159:357-358, 1989
283. 1989 Significant DQw1 association in achalasia. Dig Dis Sci 34:349-352, 1989
284. 1988 Autoantibodies to insulin are present in the sera of patients with autoimmune thyroid disease Diabetes 37(3):317-320, 1988
285. 1988 Letter, Eponyms Ann Intern Med 108:635, 1988
286. 1988 Natural killer cell activity and serum autoantibodies in women with postpartum thyroiditis J Clin Endocrinol Metab 66(5):1089-1093, 1988.
287. 1988 Immunoglobulins that cause thymocyte proliferation from a patient with Graves' disease and an enlarged thymus Am J Med 85:117-121, 1988.
288. 1988 Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen. J Immunol 140:2593-2599, 1988
289. 1988 Clinical relevance of the substitution of different brands of sustained-release theophylline J Allergy Clin Immunol 81(4):664-673, 1988
290. 1988 Immunoglobulin and T cell antigen receptor arrangements indicate that the immune response in autoimmune thyroid disease is polyclonal J Clin Endocrinol Metab 66:958-963, 1988.
291. 1988 Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid Ann Intern Med 108(1):26-30, 1988.
292. 1988 Improved results in cadaveric renal transplantation for black recipients Transplantation Proceedings 20:398-400, 1988.
293. 1987 Antibodies to porcine eye muscle in patients with Graves' ophthalmopathy: identification of serum immunoglobulins directed against unique determinants by immunoblotting and enzyme-linked immunosorbent assay J Clin Endocrinol Metab 64(3):454-460, 1987
294. 1987 Demonstration by immunoblotting of heterogeneity in the autoantibody response directed against fat cells in Graves' disease. FEBS Lett 211(1):69-72, 1987.
295. 1987 Thyrocyte specific killer cell activity is decreased in patients with thyroid carcinoma Cancer 59(11):1914-1917, 1987
296. 1987 Heterogeneity of thyroid autoantigens identified by immunoblotting Clin Immunol Immunopathol 43(3):333-342, 1987.
297. 1987 Intrinsic abnormality of thyroid cells from a patient with a Brogdingnagian goiter. J Endocrinol Invest 10(5):517-522, 1987
298. 1987 c-myc expression in the thyroid. II: Thyrocytes and peripheral and intrathyroidal lymphocytes from patients with autoimmune thyroid disease Horm Metab Res Suppl 17:66-69, 1987.
299. 1986 Killer cell activity and antibody-dependent cell-mediated cytotoxicity are normal in Hashimoto's disease J Clin Endocrinol Metab 62(5):1059-1064, 1986
300. 1986 Development of circulating antiheart antibodies as a result of coronary bypass surgery Ann Thorac Surg 41(5):507-510, 1986.
301. 1986 Pharmacodynamics of theophylline in patients on chronic therapy J Allergy Clin Immuno, Jan 1986
302. 1985 Influence of HLA-DR and racial match on graft survival in blacks receiving cyclosporine Human Immuno 13(1):51-52, 1985
303. 1985 Anti-TSH receptor antibody and anti-idiotypic antibody containing immune complexes in Graves' disease Clin Res 33:234, 1985.
304. 1985 Cyclosporine and vaccination (Letter) Drug Intel and Clin Pharm 19:679-80, Sep 1985.
305. 1985 Beta-adrenergic ligand binding antibodies (BLA) in adult, steroid dependent asthmatics J Allergy Clin Immuno, January 1985
306. 1985 A rapid, sensitive enzyme-linked immunoassay for human thyrotropin. Clin Chem 31(7):1131-1134, 1985.
307. 1985 Clinical pharmacodynamics of theophylline. J Allergy Clin Immuno 76:292-297, 1985
308. 1985 Comment: Cyclosporine and vaccination Drug Intell Clin Pharm 19(9):679-680, 1985
309. 1985 Antithyrotropin antibodies in the sera of Graves' disease patients J Clin Endocrinol Metab 61(2):217-222, 1985.
310. 1985 Comparison of four sustained-release theohylline preparations J Allergy Clin Immuno, Jan 1985.
311. 1984 Characterization of a monoclonal antibody developed against the TSH receptor Endocrinology (Suppl) Vol. 115, Sep 1984.
312. 1984 Production, isolation and characterization of anti-idiotypic antibodies directed against human anti-TSH receptor antibodies Clin Res 32(2), 261A, 1984
313. 1984 Use of immunoblotting techniques for IgE determination Annuals of Allergy 2(3), 228, 1984
314. 1984 Immediate hypersensitivity skin testing in uremia Annals of Allergy 52(3), 224, 1984
315. 1984 Anti-TSH antibodies in the sera of Graves' patients which display anti-idiotypic activity against TSH receptor purified Graves' IgG Endocrinol (Suppl) Vol. 115, Sep 1984
316. 1984 Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotropin receptor antibodies. J Clin Invest 74(2):488-495, 1984
317. 1984 Preparation of biotinylated receptor purified Graves’ IgG: a simple technique allowing direct functional assessment of TSH receptor antibody interaction with membranes. In: Autoimmunity and the Thyroid, Walfish PG, Wall JR, Volpe R (eds), Academic Press, 387-389, 1984
318. 1984 The development of monoclonal antibodies directed against putative anti-TSH receptor antibodies J Steroid Biochem 20, 1650, 1984.
319. 1983 A sensitive and rapid enzyme-linked immunosorbent assays (ELISA) for thyroid stimulating hormone receptor antibodies Clin Res 32(2), 169A, 1983
320. 1983 Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotropin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. J Clin Invest 72(4):1487-1497, 1983.
321. 1983 IgE and complement containing immune complexes in drug induced serum sickness Clin Res 31(2), 163A, 1983
322. 1983 Computer-assisted pharmacokinetic evidence that theophylline induced brochodilatory response varies with, but lags behind fluctuations in serum theophylline levels in the therapeutic range J Allergy Clin Immunol 71(1), 131, 1983.
323. 1983 Circulating beta ligand antibodies in auto-immune thyroid disease Endocrin 113, T13, 1983
324. 1983 Class of antibodies binding the thyroid stimulating hormone receptor in active Graves’ disease Endocrin 113, T2, 1983
325. 1983 Reliability of bayesian pharmacokinetic forecasting to achieve target blood levels for research purposes Clin Pharmacol Ther 33(2), 201, 1983
326. 1983 Theophylline-induced bronchodilation lags behind serum theophylline levels under non-steady state conditions Clinical Pharmacology and Therapeutics, Mar 1983.
327. 1982 The early management of hypercalcemic crisis: A case report and review of the literature Milit Med 147:756-760, 1982.
328. 1981 Pharmacokinetics of doxupram in renal failure and hypothyroidism. Brit J Clin Pharm 11(2):305-307, 1981


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.